Ayala Pharmaceuticals, Inc. (AYLA)
NASDAQ: AYLA · IEX Real-Time Price · USD
1.59
-0.02 (-1.24%)
At close: Aug 8, 2022 3:59 PM
1.58
-0.01 (-0.63%)
After-hours:
Aug 8, 2022 7:30 PM EDT
Cash Flow Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|
| Net Income
|
-40.25 | -30.15 | -17.79 | -8.87 |
| Depreciation & Amortization
|
0.17 | 0.18 | 0.15 | 0.05 |
| Share-Based Compensation
|
2.68 | 1.57 | 0.73 | 1.07 |
| Other Operating Activities
|
-0.95 | 0.85 | 1.97 | 1.39 |
| Operating Cash Flow
|
-38.36 | -27.54 | -14.95 | -6.37 |
| Capital Expenditures
|
-0.01 | -0.05 | -1.33 | -0.22 |
| Change in Investments
|
0 | 0.23 | -0.25 | -0.03 |
| Investing Cash Flow
|
-0.01 | 0.18 | -1.58 | -0.25 |
| Share Issuance / Repurchase
|
33.33 | 52.92 | 0 | 0.02 |
| Other Financing Activities
|
0 | 0 | 7.07 | 25.4 |
| Financing Cash Flow
|
33.33 | 52.92 | 7.08 | 25.42 |
| Net Cash Flow
|
-5.03 | 25.56 | -9.46 | 18.8 |
| Free Cash Flow
|
-38.36 | -27.59 | -16.28 | -6.59 |
| Free Cash Flow Margin
|
-1094.15% | -743.96% | -697.51% | - |
| Free Cash Flow Per Share
|
-2.66 | -2.80 | -3.27 | -1.34 |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).